Your browser doesn't support javascript.
loading
Immunological and virological findings in a patient with exceptional post-treatment control: a case report.
Climent, Núria; Ambrosioni, Juan; González, Tània; Xufré, Cristina; Casadellà, Maria; Noguera-Julian, Marc; Paredes, Roger; Plana, Montserrat; Grau-Expósito, Judith; Mallolas, Josep; Alcamí, José; Sánchez-Palomino, Sonsoles; Miró, José M.
Afiliação
  • Climent N; Hospital Clinic-IDIBAPS, University of Barcelona, HIV Unit, Barcelona, Spain; CIBER of infectious Diseases (CIBERINFEC), Madrid, Spain.
  • Ambrosioni J; Hospital Clinic-IDIBAPS, University of Barcelona, HIV Unit, Barcelona, Spain; CIBER of infectious Diseases (CIBERINFEC), Madrid, Spain.
  • González T; Hospital Clinic-IDIBAPS, University of Barcelona, HIV Unit, Barcelona, Spain.
  • Xufré C; Hospital Clinic-IDIBAPS, University of Barcelona, HIV Unit, Barcelona, Spain.
  • Casadellà M; IrsiCaixa AIDS Research Institute, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.
  • Noguera-Julian M; CIBER of infectious Diseases (CIBERINFEC), Madrid, Spain; IrsiCaixa AIDS Research Institute, Hospital Universitari Germans Trias i Pujol, Badalona, Spain; University of Vic-Central University of Catalonia, Vic, Catalonia, Spain.
  • Paredes R; CIBER of infectious Diseases (CIBERINFEC), Madrid, Spain; IrsiCaixa AIDS Research Institute, Hospital Universitari Germans Trias i Pujol, Badalona, Spain; University of Vic-Central University of Catalonia, Vic, Catalonia, Spain.
  • Plana M; Hospital Clinic-IDIBAPS, University of Barcelona, HIV Unit, Barcelona, Spain; CIBER of infectious Diseases (CIBERINFEC), Madrid, Spain.
  • Grau-Expósito J; Hospital Clinic-IDIBAPS, University of Barcelona, HIV Unit, Barcelona, Spain.
  • Mallolas J; Hospital Clinic-IDIBAPS, University of Barcelona, HIV Unit, Barcelona, Spain; CIBER of infectious Diseases (CIBERINFEC), Madrid, Spain.
  • Alcamí J; Hospital Clinic-IDIBAPS, University of Barcelona, HIV Unit, Barcelona, Spain; CIBER of infectious Diseases (CIBERINFEC), Madrid, Spain; Instituto de Salud Carlos III, Madrid, Spain.
  • Sánchez-Palomino S; Hospital Clinic-IDIBAPS, University of Barcelona, HIV Unit, Barcelona, Spain; CIBER of infectious Diseases (CIBERINFEC), Madrid, Spain. Electronic address: ssanchez@recerca.clinic.cat.
  • Miró JM; Hospital Clinic-IDIBAPS, University of Barcelona, HIV Unit, Barcelona, Spain; CIBER of infectious Diseases (CIBERINFEC), Madrid, Spain. Electronic address: jmmiro@ub.edu.
Lancet HIV ; 10(1): e42-e51, 2023 01.
Article em En | MEDLINE | ID: mdl-36354046
ABSTRACT

BACKGROUND:

Although antiretroviral therapy (ART) is effective in suppressing viral replication, HIV-1 persists in reservoirs and rebounds after ART has been stopped. However, a very few people (eg, elite and post-treatment controllers) are able to maintain viral loads below detection limits without ART, constituting a realistic model for long-term HIV remission. Here, we describe the HIV control mechanisms of an individual who showed exceptional post-treatment control for longer than 15 years.

METHODS:

We report the case of a Hispanic woman aged 59 years with sexually acquired acute HIV infection, who was included in an immune-mediated primary HIV infection trial involving a short course of ciclosporine A, interleukin-2, granulocyte macrophage colony-stimulating factor, and pegylated interferon alfa, followed by analytical treatment interruption. We did the following viral assays total and integrated HIV-1 DNA in CD4 T cells and rectal tissue, quantitative viral outgrowth assay, HIV-1 infectivity in peripheral blood mononuclear cells and CD4 T-cell cultures and viral inhibitory activity by natural killer (NK) and CD8 T cells. NK and T-cell phenotypes were determined by flow cytometry. HLA, killer cell immunoglobulin-like receptors, Δ32CCR5, and NKG2C alleles were genotyped.

FINDINGS:

After ART and immunomodulatory treatment, the person maintained undetectable plasma viral load for 15 years. HIV-1 subtype was CFR_02AG, CCR5-tropic. We found progressive reductions in viral reservoir during the 15-year treatment interruption total HIV DNA (from 4573·50 copies per 106 CD4 T cells to 95·33 copies per 106 CD4 T cells) and integrated DNA (from 85·37 copies per 106 CD4 T cells to 5·25 copies per 106 CD4 T cells). Viral inhibition assays showed strong inhibition of in vitro HIV replication in co-cultures of CD4 T cells with autologous NK or CD8 T cells at 12 ratio (75% and 62%, respectively). Co-cultures with NK and CD8 T cells resulted in 93% inhibition. We detected higher-than-reference levels of both NKG2C-memory-like NK cells (46·2%) and NKG2C γδ T cells (64·9%) associated with HIV-1 control.

INTERPRETATION:

We described long-term remission in a woman aged 59 years who was treated during primary HIV infection and has maintained undetectable viral load for 15 years without ART. Replication-competent HIV-1 was isolated. NKG2C-memory-like NK cells and γδ T cells were associated with the control viral replication. Strategies promoting these cells could bring about long-term HIV remission.

FUNDING:

Fondo Europeo para el Desarrollo Regional (FEDER), SPANISH AIDS Research Network (RIS), Fondo de Investigación Sanitaria (FIS), HIVACAT, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), CERCA Programme/Generalitat de Catalunya, la Caixa Foundation, and Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC). TRANSLATION For the Spanish translation of the abstract see Supplementary Materials section.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por HIV / Soropositividade para HIV Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Revista: Lancet HIV Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Espanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por HIV / Soropositividade para HIV Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Revista: Lancet HIV Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Espanha